MARVEL-AI accelerates materials innovation by combining AI, automation and advanced research from discovery to deployment.

Singapore launches its first national Embodied AI Challenge for Manufacturing, bringing together global teams to develop and ...

The Biomanufacturing Technology and Partnership (BioTAP) Funding Initiative is a new RIE2030 initiative implemented by A*STAR to strengthen Singapore's competitiveness in biopharma manufacturing ...

The graduation ceremony, jointly organised by A*STAR's Singapore Institute of Manufacturing Technology (SIMTech) and Advanced Remanufacturing and Technology Centre (ARTC), and supported by the Skills ...

Singapore researchers from RIE institutions (e.g. A*STAR, autonomous universities, academic medical centres) may apply, together with their overseas collaborator(s). Applications must involve at least ...

The Bioinformatics Consulting and Training Platform (BISCUITS) develops and applies computational approaches to understand how cells are organised, regulated and altered in health and disease. Using ...

A*STAR’s multidisciplinary research spans biomedical sciences, physical sciences, engineering, infocomm, and more. We work closely with academia, industry partners, and public agencies to translate ...

Beyond iCORE Platforms, researchers can also discover other specialised technology platforms and scientific capabilities across the A*STAR research ecosystem through iCORE. These platforms are ...

The Centre for Genome Diagnostics (CGD) was established to co-develop genomic technologies for the nucleic acid-based therapeutics and diagnostics markets in collaboration with local enterprises.

Singapore’s national research strategy is organised around four key domains - Manufacturing, Trade and Connectivity (MTC), Human Health and Potential (HHP), Urban Solutions and Sustainability (USS), ...